Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05988515 · ClinicalTrials.gov registry record · NA
AI-Assisted Treatment for Residual Speech Sound Disorders
A NA study of Speech Sound Disorder, sponsored by Syracuse University.
- Recruiting
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT05988515: Recruiting NA study of Speech Sound Disorder, sponsored by Syracuse University.
NCT05988515 is a NA study of Speech Sound Disorder that is actively recruiting participants, run by Syracuse University. The registered enrollment target is 26 participants, below the 88-participant average among 15 other Speech Sound Disorder trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05988515, a NA study of Speech Sound Disorder, is actively recruiting participants, sponsored by Syracuse University.
- RECRUITING
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this randomized-controlled trial is to determine how artificial intelligence-assisted home practice may enhance speech learning of the "r" sound in school-age children with residual speech sound disorders. All child participants will receive 1 speech lesson per week, via telepractice, for 5 weeks with a human speech-language clinician. Some participants will receive 3 speech sessions per week with an Artificial Intelligence (AI)-clinician during the same 5 weeks as the human clinician sessions (CONCURRENT treatment order group), whereas others will receive 3 speech sessions per week with an AI-clinician after the human clinician sessions end (SEQUENTIAL treatment order group.
Primary Outcome
To assess generalization of treatment gains to untreated words, participants will read a word list eliciting /ɹ/. Stimuli in each list will be presented individually in randomized order. Individual words will be isolated from the audio record of each word probe and presented in randomized order for perceptual rating by trained listeners who are blind to treatment condition and time point (but will see the written representation of each target word). We will use the change in percent correct as o
Conditions Studied
Interventions
- BEHAVIORAL Speech-Language Pathologist-led Speech Motor Chaining
- BEHAVIORAL Artificial Intelligence-led Speech Motor Chaining (CHAINING-AI)
Study Locations (1)
New York
- Syracuse University - Syracuse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2024-09-05 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What NCT05988515 shows while recruiting
NCT05988515 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 88-participant average among 15 other Speech Sound Disorder trials with a reported enrollment target (70% lower).
The record links to 1 condition, with Speech Sound Disorder appearing as the primary indexed condition, and to 2 interventions - of which Speech-Language Pathologist-led Speech Motor Chaining is the first listed.
NCT05988515 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05988515 about?
NCT05988515 is a clinical study titled "AI-Assisted Treatment for Residual Speech Sound Disorders". The goal of this randomized-controlled trial is to determine how artificial intelligence-assisted home practice may enhance speech learning of the "r" sound in school-age children with residual speech sound disorders. All child participants will receive 1 speech lesson per week, via telepractice, fo...
What is the current status of trial NCT05988515?
This trial is currently recruiting. It is a NA study. The enrollment target is 26 participants. The study started on 2024-09-05. Estimated completion is 2027-12-31.
What conditions does trial NCT05988515 study?
This clinical trial studies the following conditions: Speech Sound Disorder.
What interventions are being tested in trial NCT05988515?
The interventions under investigation include: Speech-Language Pathologist-led Speech Motor Chaining (BEHAVIORAL), Artificial Intelligence-led Speech Motor Chaining (CHAINING-AI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05988515?
This trial is sponsored by Syracuse University, which has 31 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05988515 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Speech Sound Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05988515's enrollment target sits among peer trials
26 12th of 15 higher than 4 of 15 other Speech Sound Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Speech Sound Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Simplified Ultrasound Feedback for Speech Remediation
RECRUITING · NA
-
A Developmental Framework For Linking Phonological And Morpho-syntactic Sequential Pattern Rules In DLD: Production
RECRUITING · NA
-
Evaluating the Effectiveness of Hybrid and Traditional Speech Therapy for /ɹ/ and /s/ Sound Production
RECRUITING · NA
-
Online Rotating Delivery of Perception/Production Enhanced Treatment for Rhotics
RECRUITING · NA
-
Measuring Aided Language Development
RECRUITING · NA
-
BiOfeedback, Online for Sibilant Treatment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI